论文部分内容阅读
目的总结探讨玻璃体腔注射曲安奈德联合激光光凝治疗糖尿病黄斑水肿的疗效,为临床治疗眼底疾病提供参考依据。方法选择2011年5月-2013年12月期间我院收治的36例(50眼)糖尿病黄斑水肿患者为研究对象,随机分为对照组和观察组各18例,对照组(25眼)采用单纯玻璃体腔注射曲安奈德治疗,观察组(25眼)采用玻璃体腔注射曲安奈德与激光光凝联合治疗,观察比较两组患者临床治疗效果。结果观察组治疗总有效率96.00%明显高于对照组76.00%,差异具有统计学意义(P<0.05)。结论对于糖尿病黄斑水肿患者给予玻璃体腔注射曲安奈德联合激光治疗能有效控制并发症,提高临床治疗效果,促进患者视功能恢复,临床值得推广使用。
Objective To summarize the curative effect of intravitreal injection of triamcinolone acetonide combined with laser photocoagulation on diabetic macular edema and to provide a reference for clinical treatment of retinal diseases. Methods Thirty-six patients (50 eyes) with diabetic macular edema admitted from May 2011 to December 2013 in our hospital were selected and randomly divided into control group (18 cases) and observation group (18 cases). The control group (25 cases) Vitreous cavity injection of triamcinolone acetonide treatment, the observation group (25 eyes) intravitreal triamcinolone acetonide injection and laser photocoagulation combined treatment, the clinical efficacy of the two groups were observed and compared. Results The total effective rate of observation group was 96.00%, which was significantly higher than that of control group (76.00%), the difference was statistically significant (P <0.05). Conclusions Intravitreous injection of triamcinolone acetonide and laser combined with laser treatment in patients with diabetic macular edema can effectively control the complications, improve the clinical therapeutic effect and promote the recovery of visual function in patients with diabetic macular edema, which is worthy of clinical promotion.